(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K
|
|
- Kathleen Gilmore
- 5 years ago
- Views:
Transcription
1 DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. CME) for > 5 5 >$5/1 Abbott Laboratories Abbott Vascular Business (formerly Abbott Vascular Devices) AbbVie Abiomed Acceleron Pharma Inc Acerta Pharma ACIST Medical Systems, Inc AegisCN LLC Aires Akili Interactive Labs Akros page 1 of 9
2 CME) for > 5 5 >$5/1 Alexion Amgen, Inc Amylin, Inc. ARCA biopharma Armis Biopharma Astellas Scientific and Medical Affairs Inc AstraZeneca Baseline Study LLC Basilea Pharmaceutica International Ltd Bayer AG Biosensors International Group Ltd Boehringer Ingleheim Boston Scientific Corporation Bristol Myers Squibb 2 of 9
3 CME) for > 5 5 >$5/1 Cempra, Inc. ContraFect Corporation CPC Clinical CryoLife Inc CSL Limited DAIICHI SANYO COMPANY, LIMITED Datavant Inc David H Murdock Inst for Business and Culture Duke Clinical Institute Durata Therapeutics Eiger BioPharmaceutical s Inc Einstein HC Network Philadelphia 3 of 9
4 CME) for > 5 5 >$5/1 Elesvier Eli Lilly & Eureka Therapeutics Evalve, Inc. Ferring Filament BioSolutions Galectin Therapeutic Genentech General Electric Genetic Alliance Genzyme Corporation German AFNET Gilead GlaxoSmithline plc Grifols HeartFlow 4 of 9
5 CME) for > 5 5 >$5/1 Intarcia Therapeutics, Inc. Intra-Cellular Therapies Inc Ironwood Janssen Pharmaceutica Products, L.P. Janssen and Development Janssen Scientific Affairs, LLC Japanese Org for Med Device Devlpt Johnson and Johnson Pharmaceutical and Development em Pharm Inc Ligand Luitpold, Inc. 5 of 9
6 CME) for > 5 5 >$5/1 Lundbeck Mallinckrodt Marinus Inc Medtronic AVE Medtronic PLC Medtronic Vascular, Inc (formerly Medtronic AVE) Merck & Co, Inc. Mercy Health System Murdock Myoardia Inc Novartis Pharmaceutical Olympus Corporation Oncternal Therapeutics OrbusNeich 6 of 9
7 CME) for > 5 5 >$5/1 Otsuka America Pharmaceutical, Inc PATH PENTAX Medical Pfizer Purdue Pharma Reflexion Health Regeneron, Inc ReNeuron Triangle Institute ResMed Corp Roche Diagnostics Roche Diagnostics Corp Roche Group Roche Labs Sanofi Genzyme Sanofi-Aventis Sanofi-Synthelabo 7 of 9
8 CME) for > 5 5 >$5/1 Society of Thoracic Surgeons Summit Svelte Medical Systems Inc. Swedish Orphan Biovitrum AB Tacere Therapeutics Taiwanj Ltd Takeda Pharmaceutical North America Inc TESARO Inc TEVA Industries Theravance Biopharma Thrombosis Institute Ultragenyx 8 of 9
9 CME) for > 5 5 >$5/1 United Health Network Abbott Laboratories Pluristem Therapeutics, Inc. Column Explanations: (1)Funding is provided for my effort in research grants or contracts for multi-center projects in which I serve as either the Chairman, Co-Chairman, Executive or Steering Committee member or I am involved as a DCRI faculty leader for specific aspects in a project. A check in this column denotes that I am involved in such a research contract. Payments for the work performed for these contracts are made to the. A portion of my salary as a faculty member, representative of effort on the project, is supported by these funds. (2)A research grant company supports the expenses associated with projects in the DUHS that are under my direction. (3)I provide educational activities or deliver occasional lectures that generate revenue company. All revenues from these activities are paid to the. None of it is taken for personal income. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. (4)I receive personal income outside of my salary for consulting or other services (Including CME) company. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. (5)I receive personal income outside of my salary for consulting or other non-cme services company. The three columns represent annual payments of more than $5,000, between $5,000 and $25,000, and in excess of $25,000 per year company. personally receive royalties in excess of $5,000 per year company. (7)I, or an immediate member of my family, have equity (with shareholder voting privileges) in this company of either > $5,000 or > 1. 9 of 9
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Jan 2015 to December 2015 Name: Adam DeVore Title: Instructor in Medicine Address: 2400 Pratt Street, Durham, NC 27705 Please complete the applicable
More informationMethod of Declaration. Hospitality/Interest/Sponsorship
Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12
More informationGLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationOwnership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None
AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (Comprehensive) ACCF/AHA 2013 GUIDELINE FOR THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (October, 2012) Committee Member Patrick T. O Gara,
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
More informationTRENDS IN IP DISPUTES
ASSOCIATION OF CORPORATE COUNSEL LITIGATION COMMITTEE APRIL 25, 2017 TRENDS IN IP DISPUTES DAVID YURKERWICH MANAGING DIRECTOR IP PRACTICE LEADER 1 AGENDA Patent infringement and IPR filing trends Operating
More informationAssociate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
More informationPrevious Attendees List:
Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare
More informationHEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging
Author Listing of Comprehensive Relationships With Industry and Other Entities for the ACCF/AHA/ASE/ASNC/HRS/IAC/MENDED HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of
More information2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions
2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions FRIDAY, 4 MAY 8:30 AM 3 PM New York Genome Center 101 Avenue of the Americas New York, NY 10013 HBAnet.org Event
More informationThe 2011 EU industrial R&D investment SCOREBOARD
1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at
More informationEarly Valuation. Company Portfolio
Early Valuation Company Portfolio The current strategy Idea PoC Regulatory Clinical Development Basic Science / Experts Operations Marketing / KOL Commercial Health Innovation Technology Transfer 1 I d
More informationBorn Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016.
Board of Directors Håkan Björklund Chairman Born 1956. Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016. Other appointments: Currently serves as Industry Executive at Avista Capital
More information2017 IPCC Attendee List
2017 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2017 Company Abbvie Inc. AbbVie Inc. AbbVie Inc. AgTech Accelerator AIPLA Akebia Therapeutics, Inc Alkermes, Inc. Alkermes, Inc.
More informationMixed Signals: Understanding the Outlook for Pharma R&D Spending Through
Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through 2015 www.pharmsource.com 1 Presenters Jim Miller President and Founder, PharmSource Saul Richmond, PhD Director of Market Intelligence,
More informationLife Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack
C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,
More informationAppendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics
Appendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics Conference Co-Chairs Dr. Richard Popp Acumen Medical Pelikan Technologies Percardia, Inc. Acumen Medical Agilent
More informationInnovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
More information2018 IPCC Attendee List
2018 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2018 Title Head of Intellectual Property Vice President IP Asst. Program Officer Health Supervisor Public Health Asst. Health Youth
More informationCardiac Safety Research Consortium: A Decade of CSRC. Mitchell W. Krucoff, MD, FACC
Cardiac Safety Research Consortium: A Decade of CSRC Mitchell W. Krucoff, MD, FACC Professor, Medicine/Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Co-Director, CSRC
More informationThe 2010 EU industrial R&D investment SCOREBOARD
1 The 2010 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández 2 Contents 1. Background 2. Overall R&D trends 3. Top R&D companies 4. R&D by region 5. R&D
More informationNOTICE OF ANNUAL GENERAL MEETING. Thursday 30 March 2017 at am. H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby
TO THE SHAREHOLDERS OF H. LUNDBECK A/S NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Thursday 30 March 2017 at 10.00 am The general
More informationReinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
More informationOther appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More information2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA
Learner Notification 2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA Acknowledgement of Financial Commercial Support No financial commercial support was received for this educational activity.
More informationHESI Annual Meeting January 19, Welcome!!!! Meeting of the. HESI Assembly of Members. Dr. James MacDonald President of HESI 01/19/09
HESI Annual Meeting January 19, 2009 Welcome!!!! Meeting of the HESI Assembly of Members Dr. James MacDonald President of HESI The HESI logo... Depicts our commitment to the tripartite approach... Government!
More informationPeter Forman President & CEO South Shore Chamber of Commerce
June 28, 2018 Peter Forman President & CEO South Shore Chamber of Commerce George Toma Chairman South Shore Chamber of Commerce Jim McDonough President & CEO Envision Bank Elliot F. Eisenberg, Ph.D. President:
More informationSZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.
SZF Associates Company Mission SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. We work with strategic and tactical decision
More informationPROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium
PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data
More informationACC.17 Program Committee Disclosures of Relationships With Industry Disclosures
ACC.17 Program Committee of Relationships With Industry Name Brian G. Abbott, MD, J. Dawn Abbott, MD, DATA SAFETY MONITORING BOARD - Pfizer Nazem Akoum, MD, CONSULTANT FEES/HONORARIA - Biotronik Karen
More informationBREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017
BREAKTHROUGH CONVENTION SUMMARY JUNE 19-22 SAN DIEGO CONVENTION.BIO.ORG #BIO BIO BY THE NUMBERS FEATURING SEVERAL THEMATIC EXHIBITS 16,123 ATTENDEES 74 48 COUNTRIES STATES 18,000 MORE THAN EXHIBITORS 41,400
More informationMonetizing Early-Stage R&D Assets. March 18, 2015
Monetizing Early-Stage R&D Assets March 18, 2015 Disclaimer Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst
More informationSkystar Bio-Pharmaceutical Co SKBI
Morningstar Analyst Rating Page 1 of 6 Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF $ 0.00 [0.00 0.00 % $ 0.00 0.00-0.00 0.00-0.10
More informationLIGHTHOUSE. The Science of Pharmaceutical Manufacturing
The Science of Pharmaceutical Manufacturing The Power of headspace inspection insight into the process. On the other hand, rapid non-destructive headspace analysis from is a powerful analytical tool for
More informationInstitutional, Organizational, or Other Financial. Ownership/ Partnership/Principa. Speakers Bureau. Reviewer Representation Employment Consultant
Relationships With Industry and Other Entities (Comprehensive) 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (August 2018) Institutional,,
More informationDISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Controversies and Advances in the Treatment of Cardiovascular Disease The Sixteenth in the Series November 17 & 18, 2016 Montage Beverly Hills DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS In accordance
More informationCommittee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness
2013 ACCF/AHA/SCAI Clinical Competence Statement on Coronary Interventional Procedures (Revision of 2007 Statement) Online Author Listing of Comprehensive Relationships With Industry and Other Entities
More informationCorporate Compliance & Transparency
4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating
More informationSkystar Bio-Pharmaceutical Co SKBI
Morningstar Analyst Rating Page 1 of 6 Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF $ 0.01 [0.00 0.00 % $ 0.01 0.01-0.01 0.00-0.20
More informationEuropean companies outpace American counterparts in R&D investment growth for the first time in five years
IP/08/1504 Brussels, 15 October 2008 European companies outpace American counterparts in R&D investment growth for the first time in five years R&D investment by EU companies has increased by 8.8% compared
More information2018 AATS/ACC/SCAI/STS
Reviewer Relationships With Industry and Other Entities (Comprehensive) 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Requirements for Transcatheter Aortic
More informationOffice of Inspector General Update
Office of Inspector General Update 15th Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum November 3, 2014 Mary E. Riordan, Senior Counsel Office of Counsel to the Inspector
More informationLife Sciences. An evolving industry: Today s clusters creating tomorrow s breakthroughs. New Jersey JLL Research
Life Sciences New Jersey 2017 An evolving industry: Today s clusters creating tomorrow s breakthroughs JLL Research 2 New Jersey Over the course of the past 130 years, the pharmaceutical/life sciences
More information7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August Exhibitor Prospectus. About the Course
7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August 2010 Exhibitor Prospectus About the Course During Scripps Clinic s Oncology Update course, clinical experts will review
More informationLIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationEuropean Patent Reform Forum USA December , New York
European Patent Reform Forum USA December 8 2015, New York Delegate List Job Title Organisation SVP/ Senior IP Law ACell ADP Law Vice President Director Senior Manager, Licensing, IP Law Global, Diabetes
More informationACC.18 ABSTRACT REVIEWERS Disclosures
Name A. Michael Lincoff, M.D., FACC RESEARCH/RESEARCH GRANTS - AbbVie, Inc., Amgen, Astra Zeneca, Cerenis, CSL Behring, Edwards Lifesciences, Esperion, Ethicon, Infraredx, Janssen, Johnson & Johnson, Lilly,
More informationVALUE IN HEALTH 20 (2017) A384 A397
A384 VALUE IN HEALTH 20 (2017) A384 A397 DISCLOSURE INFORMATION Research Presentations Financial Disclosure Statements The International Society for Pharmacoeconomics and Outcomes Research asked all abstract
More informationIPCAA. Regulatory awareness still needs improving. INTERNATIONAL PHARMACEUTICAL CONGRESS ADVISORY ASSOCIATION No. 35 July 2010
IPCAA NEWS Regulatory awareness still needs improving Following continuing efforts to promote awareness of pharmaceutical industry codes and regulatory constraints on sponsors for medical congresses, it
More informationThis report is prepared by:
Access to Medicine Index 2010 Access to Medicine Foundation The Access to Medicine Foundation is an international not for profit organization dedicated to improving access to medicines to societies in
More informationLast Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF
Page 1 of 6 Morningstar Analyst Rating. Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF $ 86.57 ]1.05 1.23 % $ 86.09 85.93-86.75
More informationManagement Team. Bruce C. Cozadd Chairman and Chief Executive Officer
Bruce C. Cozadd Chairman and Chief Executive Officer Bruce Cozadd joined Jazz Pharmaceuticals at its inception and was appointed Jazz Pharmaceuticals Chief Executive Officer in April 2009. From 2003 until
More informationGrand Hyatt Shanghai New Growth Models For China
Grand Hyatt Shanghai New Growth Models For China At the PharmAsia Summit Shanghai, Elsevier and BayHelix will focus on new R&D and commercial models in a rapidly changing China. Given demographic changes
More informationCase BLS Doc 258 Filed 01/31/19 Page 1 of 2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE
Case 18-12439-BLS Doc 258 Filed 01/31/19 Page 1 of 2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ) In re: ) Chapter 11 ) EGALET CORPORATION, et al., ) Case No. 18-12439 (BLS) ) )
More informationGilead Sciences. Very interesting in all areas. COMPANY Gilead Sciences Inc. INDUSTRY Biotechnology TYPE Public Company TICKER NasdaqGS:GILD
Simply Wall St provides a completely new visual way to invest in the stock market. To see other infographic reports like this one for Apple check out simplywall.st. Very interesting in all areas. COMPANY
More informationMARKUSH FOR PATENT ANALYSIS. Steve Hajkowski ChemAxon UGM Budapest 2013
MARKUSH FOR PATENT ANALYSIS Steve Hajkowski ChemAxon UGM Budapest 2013 THOMSON REUTERS MARKUSH DATA Indexing for 2.4 million patent families 1.6m Markush structures, re-drawn & stored in Thomson Reuters
More informationBOARD OF DIRECTORS CHAIRMAN Troy Sarich, Ph.D. Adeana R. Bishop, Ph.D. Raymond Carr VICE-CHAIRMAN Christos Christodoulatos, Ph.D.
2015 16 BOARD OF DIRECTORS CHAIRMAN Troy Sarich, Ph.D. Janssen Scientific Affairs, LLC a Johnson & Johnson company Vice President, Real World Evidence VICE-CHAIRMAN Christos Christodoulatos, Ph.D. Stevens
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationWilliam E. Solander. Case Highlight
...an insightful patent litigator with sound judgment who is capable of achieving effective results when solving legal and business issues. (Best Lawyers 2014) Contact William E. Solander Partner wsolander@fchs.com
More informationACC.13 Committee Disclosures Page 1 of 9
ACC.13 Program Committee Disclosures Last First Direcr Grants Alexander Karen P. Gilead Sanofi Aventis Ananthasu Karthikeya Lantheus Imaging bramaniam n Lantheus Imaging, Astellas Pharma US, Inc Astellas
More informationWe Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations
We Work For Health Champions Awards Class of 2012 Brief Biographical Information (Alphabetical by Member Company) The We Work For Health Champion Awards are given annually to those to individuals who have
More informationIP for Development Indian Approach
ARAB REPUBLIC OF EGYPT MINISTRY OF FOREIGN AFFAIRS ACADEMY OF SCIENTIFIC RESEARCH AND TECHNOLOGY WORLD INTELLECTUAL PROPERTY ORGANISATION Second WIPO Inter-Regional Meeting on South-South Cooperation on
More informationAre European firms falling behind in the global corporate research race?
Policy Contribution Issue n 06 April 2018 Are European firms falling behind in the global corporate research race? Reinhilde Veugelers Executive summary Reinhilde Veugelers (reinhilde.veugelers@ bruegel.org)
More informationvision without limits BIOTECH CANTY PROCESS TECHNOLOGY BUFFALO DUBLIN THAILAND
vision without limits BIOTECH CANTY PROCESS TECHNOLOGY BUFFALO DUBLIN THAILAND Large, reflection-free lighting with rugged fiber optics Sanitary LED Lighting APPLICATIONS Biotech Applications Fermentors
More informationBaxter 2007 Investor Conference March 14, 2007
Joy A. Amundson is a corporate vice president of Baxter Healthcare Corporation and president of the company s BioScience business. In this position, she is responsible for the development and worldwide
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationGMPs FOR CURRENT TIMES
A MUST ATTEND GMP event for all pharmaceutical companies! GMPs FOR CURRENT TIMES APRIL 9-10, 2019 ORLANDO, FLORIDA Program produced by REGISTER EARLY! The top producer of premier pharmaceutical conferences
More information30th Annual Oncology Nurses Symposium
E X H I B I T O R P R O S P E C T U S 30th Annual Oncology Nurses Symposium S E P T E M B E R 2 6-2 9, 2 0 1 0 H I L T O N S A N D I E G O R E S O R T Scripps Conference Services & CME www.scripps.org/conferenceservices
More informationPwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease
More informationResearched Medicines Industry Association of New Zealand Incorporated
MResearched Medicines Industry Researched Medicines Industry Association of New Zealand Incorporated Submission on Patents Bill to the Commerce Select Committee July 2009 Researched Medicines Industry
More informationHeart Valve Summit: Medical, Surgical and Interventional Decision Making
Disclosure/Conflict of Interest Statement As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationReference List Cha, Myoung., and Theresa Lorriman. February Why Pharma megamergers work. McKinsey&Company Our insights. Ward, Andrew.
Reference List Cha, Myoung., and Theresa Lorriman. February 2014. Why Pharma megamergers work. McKinsey&Company Our insights. Ward, Andrew. September 24, 2015. Pharmaceuticals: Value over Volume. Financial
More informationOfficer Director etc. Ownership Partnership Principal. Speaker's Bureau
ACC.14 and TCT@ACC-i2 Program Committees' Disclosures of Relationships with Industry Moniring Last Abbott J. Dawn YES YES Pfizer Bosn scientific Adams David H. YES YES Medtronic, Edwards Lifesciences,
More informationNew Rhein concludes successful investment in Chase Pharmaceuticals via sale to Allergan
New Rhein concludes successful investment in Chase Pharmaceuticals via sale to Allergan NEWS PROVIDED BY New Rhein Healthcare Investors LLC Nov 22, 2016, 04:57 ET CHICAGO, Nov. 22, 2016 /PRNewswire/ --
More informationTransforming the right molecules into the best medicines TM
August 2017 Transforming the right molecules into the best medicines TM We are passionate in our mission to improve the health of patients by providing novel strategic alternatives to companies wishing
More informationHealthcare and Life Sciences Group. Mergers & Acquisitions
Healthcare and Life Sciences Group Mergers & Acquisitions Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationTRANSLATIONAL SCIENCE
TRANSLATIONAL SCIENCE A Discussion of Best Practices and Unique Models Wednesday January 31, 2018 at The NYSCF Research Institute HRA TRI-STATE REGIONAL MEETING 31 Wednesday January, 2018 AGENDA 8:30 AM
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Sullivan & Cromwell LLP 2013 LG4690 Prior results do not guarantee a similar outcome. Through decades of experience in many of the transactions
More informationHealthcare Industry Update
Healthcare Industry Update Tuesday, April 17 th, 2018 THE ORIGIN RX State of the Union This past Friday the 13 th was anything but unlucky for US-based pot growers. Cannabis stocks on both sides of the
More informationAnnual Benefit-Risk Workshop
Annual Benefit-Risk Workshop Implementing an Internationally Acceptable Framework for the Benefit- Risk Assessment of Medicines: How close are we to this objective? 20-21 June 2013 PROGRAMME Venue: The
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationWomen leaders transforming the future through gender partnership
On behalf of the 3BC steering committee, HBA senior advisory board and board of directors, we wish to warmly invite you to: Building Better Business Connections (3BC) annual executive summit Women leaders
More informationNOTICE OF ANNUAL GENERAL MEETING. Tuesday 26 March 2019 at 10: 00 am. H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby
TO THE SHAREHOLDERS OF H. LUNDBECK A/S NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Tuesday 26 March 2019 at 10: 00 am The general
More informationThe EU industrial R&D investment SCOREBOARD
1 The EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández The EU industrial R&D investment SCOREBOARD 2 Contents 1. Background 2. Overall R&D trends 3. Top
More informationTODAY LETTER DATED
TODAY LETTER DATED 05.07.2018 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF LETTER 1. M/S. CLIANTHA RESEARCH LTD., AHMEDABAD-380054 23483 CLARIFICATION LETTER 2. M/S. EMCURE LIMITED, PUNE-
More informationMATCHING GIFT COMPANY LIST
MATCHING GIFT COMPANY LIST This is a list of corporations that have matched donations to events benefiting Susan G. Komen for the Cure in the past. Please review your corporation s matching gift guidelines
More informationUBS Pathfinders Trust, Treasury and Growth Stock Series 23
Dear Valued Client: This annual statement contains important information about your investment. The UBS Unit Trust thanks you for making this Pathfinders Trust a part of your financial plan. If you have
More informationThe importance of transnational corporations in research and development activities in the world
Jagiellonian Journal of Management vol. 3 (2017), no. 2, pp. 65 75 doi:10.4467/2450114xjjm.17.005.7735 www.ejournals.eu/jjm The importance of transnational corporations in research and development activities
More informationThe general meeting will be held at the offices of the Company at: H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby
H. Lundbeck A/S Ottiliavej 9 Tel +45 36 30 13 11 E-mail investor@lundbeck.com DK-2500 Valby, Copenhagen www.lundbeck.com CVR number: 56759913 LEI code: 5493006R4KC2OI5D3470 Corporate Release Notice of
More informationDisclosures of Relevant Financial Relationships
Disclosures of Relevant Financial Relationships Disclosure Policy It is the policy of the Society of Cardiovascular Anesthesiologists (SCA) that the planners, faculty, and reviewers disclose the existence
More informationVALUE IN HEALTH 18 (2015) A308-A318
A308 DISCLOSURE INFORMATION Research Presentations Financial Disclosure Statements The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose fi nancial
More information